Gryphon Financial Partners »

United Therapeutics Corporation shares owned by Gryphon Financial Partners

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Gryphon Financial Partners from 13F filings

Historical chart of Gryphon Financial Partners investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Gryphon Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Gryphon Financial Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $408k 973 419.21
2025-06-30 $285k 992 287.35
2025-03-31 $229k 743 308.27
2024-09-30 $210k 586 358.35
2019-06-30 $2.0k 32 62.50

More positions owned by Gryphon Financial Partners

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Shopify Cl A Sub Vtg Shs (SHOP)
Meta Platforms Cl A (META)
Warner Bros Discovery Com Ser A (WBD)
Abbvie (ABBV)
Ishares Tr Msci Acwi Etf (ACWI)
Abbott Laboratories (ABT)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Targa Res Corp (TRGP)

View all positions for Gryphon Financial Partners

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation